{"id":3939,"date":"2014-08-22T10:10:58","date_gmt":"2014-08-22T09:10:58","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=3939"},"modified":"2014-09-19T13:04:00","modified_gmt":"2014-09-19T12:04:00","slug":"nye-publikasjoner-27","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2014\/08\/22\/nye-publikasjoner-27\/","title":{"rendered":"Nye publikasjonerNew Publications"},"content":{"rendered":"

Uker 27-34\/2014.<\/strong><\/p>\n

Weeks 27-34\/2014.<\/strong><\/strong><\/p>\n

<\/p>\n

An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer.<\/a>
\nMannelqvist M, Wik E, Stefansson IM, Akslen LA.
\nPLoS One. 2014 Jun 6;9(6):e98787. PMID: 24905342<\/p>\n

Effects of duodenal switch alone or in combination with sleeve gastrectomy on body weight and lipid metabolism in rats.
\n<\/a>Gudbrandsen OA, Kodama Y, Mj\u00f8s SA, Zhao CM, Johannessen H, Brattbakk HR, Haugen C, Kulseng B, Mellgren G, Chen D.
\nNutr Diabetes. 2014 Jun 30;4:e124. PMID: 24979153<\/p>\n

GWAS-based pathway analysis differentiates between fluid and crystallized intelligence.
\n<\/a>Christoforou A, Espeseth T, Davies G, Fernandes CP, Giddaluru S, Mattheisen M, Tenesa A, Harris SE, Liewald DC, Payton A, Ollier W, Horan M, Pendleton N, Haggarty P, Djurovic S, Herms S, Hoffman P, Cichon S, Starr JM, Lundervold A, Reinvang I, Steen VM, Deary IJ, Le Hellard S.
\nGenes Brain Behav. 2014 Jun 28. PMID: 24975275<\/p>\n

Genetic diversity of norovirus in hospitalised diarrhoeic children and asymptomatic controls in Dar es Salaam, Tanzania.
\n<\/a>Moyo S, Hanevik K, Blomberg B, Kommedal O, Vainio K, Maselle S, Langeland N.
\nInfect Genet Evol. 2014 Aug;26:340-7. PMID: 24960396<\/p>\n

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?
\n<\/a>Reikvam H, Brenner AK, Nepstad I, Sulen A, Bruserud O.
\nExpert Opin Ther Targets. 2014 Aug;18(8):929-44. PMID: 24956934<\/p>\n

Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
\n<\/a>Trovik LH, Ovrebo K, Almquist M, Haugland HK, Rissler P, Eide J, Engellau J, Monge OR, Nyhus AB, Elde IK, Jebsen NL.
\nActa Oncol. 2014 Jul 7:1-8. PMID: 25000415<\/p>\n

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive<\/strong> disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
\n<\/a>Wik E, Trovik J, Kusonmano K, Birkeland E, Raeder MB, Pashtan I, Hoivik EA, Krakstad C, Werner HM, Holst F, Mj\u00f8s S, Halle MK, Mannelqvist M, Mauland KK, Oyan AM, Stefansson IM, Petersen K, Simon R, Cherniack AD, Meyerson M, Kalland KH, Akslen LA, Salvesen HB.
\nGynecol Oncol. 2014 Jul 1. PMID: 24995579<\/p>\n

The frequencies of IFN\u03b3+IL2+TNF\u03b1+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON\u00ae gold in-tube response in a prospective study of healthy indian adolescents.
\n<\/a>Jenum S, Grewal HM, Hokey DA, Kenneth J, Vaz M, Doherty TM, Jahnsen FL; TB Trials Study Group.
\nPLoS One. 2014 Jul 3;9(7):e101224. PMID: 24992314<\/p>\n

Haemodynamic differences between pancuronium and vecuronium in an experimental pig model.
\n<\/a>Grong K, Salminen PR, Stangeland L, Dahle GO.
\nVet Anaesth Analg. 2014 Jul 2. PMID: 24985148<\/p>\n

Maternal hormonal contraceptive use and offspring overweight or obesity.
\n<\/a>Jensen ET, Daniels JL, St\u00fcrmer T, Robinson WR, Williams CJ, Moster D, Juliusson PB, Vejrup K, Magnus P, Longnecker MP.
\nInt J Obes (Lond). 2014 Jul 2. PMID: 24984751<\/p>\n

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy.
\n<\/a>Gjertsen BT, Sch\u00f6ffski P.
\nLeukemia. 2014 Jul 16. PMID: 25027517<\/p>\n

The C-terminal half of the \u03b12C-adrenoceptor determines the receptor’s membrane expression level and drug selectivity.
\n<\/a>Jahnsen JA, Uhl\u00e9n S.
\nNaunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1031-40. PMID: 23868076<\/p>\n

ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes.
\n<\/a>Ussar S, Lee KY, Dankel SN, Boucher J, Haering MF, Kleinridders A, Thomou T, Xue R, Macotela Y, Cypess AM, Tseng YH, Mellgren G, Kahn CR.
\nSci Transl Med. 2014 Jul 30;6(247):247ra103. PMID: 25080478<\/p>\n

Current status of molecular biomarkers in endometrial cancer.
\n<\/a>Werner HM, Salvesen HB.
\nCurr Oncol Rep. 2014 Sep;16(9):403. PMID: 25064587<\/p>\n

Myocardial injury in a 41-year-old male treated with methylphenidate: a case report.
\n<\/a>Hole LD, Schj\u00f8tt J.
\nBMC Res Notes. 2014 Jul 29;7:480. PMID: 25073534<\/p>\n

Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.
\n<\/a>Schj\u00f8tt J, Bergman J.
\nDrug Healthc Patient Saf. 2014 Jul 1;6:89-92. PMID: 25061339<\/p>\n

Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.
\n<\/a>Qui\u00f1ones M, Al-Massadi O, Fern\u00f8 J, Nogueiras R.
\nMol Cell<\/strong> Endocrinol. 2014 Aug 7. PMID: 25109279<\/p>\n

Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-\u03b3-mediated immune activation in the community-based Hordaland Health Study.
\n<\/a>Theofylaktopoulou D, Ulvik A, Midttun O, Ueland PM, Vollset SE, Nyg\u00e5rd O, Hustad S, Tell GS, Eussen SJ.
\nBr J Nutr. 2014 Aug 8:1-8. PMID: 25105221<\/p>\n

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.<\/a>
\nFrentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, J\u00f8rgensen LB, K\u00fccherer C, Struck D, Schmit JC, Vercauteren J, Asj\u00f6 B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-St\u00f6ckl E, S\u00f6nnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme.
\nBMC Infect Dis. 2014 Jul 21;14:407. PMID: 25047543<\/p>\n

Akutt promyelocyttleukemi.
\n<\/a>Reikvam H, Hovland R, Bruserud O.
\nTidsskrift for den Norske laegeforening 2014 May 27;134:1052-5. Norwegian.<\/p>\n

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.
\n<\/a>Koro C, Bielecka E, Dahl-Knudsen A, Enghild JJ, Scavenius C, Brun JG, Binder V, Hellvard A, Bergum B, Jonsson R, Potempa J, Blom AM, Mydel P.
\nEur J Immunol. 2014 Aug 13. PMID: 25130613<\/p>\n

Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix.
\n<\/a>Halle MK, Krakstad C, Engerud H, Bertelsen B, Salvesen HB.
\nPathol Res Pract. 2014 Jul 22. PMID: 25123963<\/p>\n

Irritable bowel syndrome and chronic fatigue six years after Giardia infection: a controlled prospective cohort study.
\n<\/a>Hanevik K, Wensaas KA, Rortveit G, Eide GE, M\u00f8rch K, Langeland N.
\nClin Infect Dis. 2014 Aug 12. PMID: 25115874<\/p>\n

One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
\n<\/a>Tandstad T, St\u00e5hl O, H\u00e5kansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, S\u00f6derstr\u00f6m K, Cavallin-St\u00e5hl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G; on behalf of SWENOTECA.
\nAnn Oncol. 2014 Aug 11. PMID: 25114021<\/p>\n

[Cardiac resynchronization therapy in heart failure–Norwegian guidelines].
\n<\/a>Holm T, F\u00e6restrand S, Larsen AI, J\u00f8nland KB, Gullestad L, Dickstein K, K\u00f6pp U, Sirnes PA, Tande P, Steen T, Kongsg\u00e5rd E.
\nTidsskr Nor Laegeforen. 2014 May 27;134(10):E1-17. Norwegian. PMID: 24865746<\/p>\n

[Cardiovascular risk assessment for the use of ADHD drugs in children].
\n<\/a>Berg A, Br\u00e5tane E, Odland HH, Brudvik C, Rosland B, Hirth A.
\nTidsskr Nor Laegeforen. 2014 Apr 8;134(7):710-4. Review. Norwegian. PMID: 24721858<\/p>\n

Effects of neonatal programming on hypothalamic mechanisms controlling energy balance.
\n<\/a>Contreras C, Novelle MG, Leis R, Di\u00e9guez C, Skrede S, L\u00f3pez M.
\nHorm Metab Res. 2013 Dec;45(13):935-44. PMID: 23913119<\/p>\n

Basert p\u00e5 siste ukes s\u00f8k p\u00e5<\/i><\/b> \u201c<\/i>Department of Clinical Science AND Bergen<\/i><\/strong>\u201d. Hvis du har publikasjoner som ikke favnes av dette s\u00f8ket, send referansen til olivera.bozickovic@k2.uib.no<\/a>.<\/i><\/p>\n

An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer.<\/a>
\nMannelqvist M, Wik E, Stefansson IM, Akslen LA.
\nPLoS One. 2014 Jun 6;9(6):e98787. PMID: 24905342<\/p>\n

Effects of duodenal switch alone or in combination with sleeve gastrectomy on body weight and lipid metabolism in rats.
\n<\/a>Gudbrandsen OA, Kodama Y, Mj\u00f8s SA, Zhao CM, Johannessen H, Brattbakk HR, Haugen C, Kulseng B, Mellgren G, Chen D.
\nNutr Diabetes. 2014 Jun 30;4:e124. PMID: 24979153<\/p>\n

GWAS-based pathway analysis differentiates between fluid and crystallized intelligence.
\n<\/a>Christoforou A, Espeseth T, Davies G, Fernandes CP, Giddaluru S, Mattheisen M, Tenesa A, Harris SE, Liewald DC, Payton A, Ollier W, Horan M, Pendleton N, Haggarty P, Djurovic S, Herms S, Hoffman P, Cichon S, Starr JM, Lundervold A, Reinvang I, Steen VM, Deary IJ, Le Hellard S.
\nGenes Brain Behav. 2014 Jun 28. PMID: 24975275<\/p>\n

Genetic diversity of norovirus in hospitalised diarrhoeic children and asymptomatic controls in Dar es Salaam, Tanzania.
\n<\/a>Moyo S, Hanevik K, Blomberg B, Kommedal O, Vainio K, Maselle S, Langeland N.
\nInfect Genet Evol. 2014 Aug;26:340-7. PMID: 24960396<\/p>\n

Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?
\n<\/a>Reikvam H, Brenner AK, Nepstad I, Sulen A, Bruserud O.
\nExpert Opin Ther Targets. 2014 Aug;18(8):929-44. PMID: 24956934<\/p>\n

Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
\n<\/a>Trovik LH, Ovrebo K, Almquist M, Haugland HK, Rissler P, Eide J, Engellau J, Monge OR, Nyhus AB, Elde IK, Jebsen NL.
\nActa Oncol. 2014 Jul 7:1-8. PMID: 25000415<\/p>\n

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive<\/strong> disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
\n<\/a>Wik E, Trovik J, Kusonmano K, Birkeland E, Raeder MB, Pashtan I, Hoivik EA, Krakstad C, Werner HM, Holst F, Mj\u00f8s S, Halle MK, Mannelqvist M, Mauland KK, Oyan AM, Stefansson IM, Petersen K, Simon R, Cherniack AD, Meyerson M, Kalland KH, Akslen LA, Salvesen HB.
\nGynecol Oncol. 2014 Jul 1. PMID: 24995579<\/p>\n

The frequencies of IFN\u03b3+IL2+TNF\u03b1+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON\u00ae gold in-tube response in a prospective study of healthy indian adolescents.
\n<\/a>Jenum S, Grewal HM, Hokey DA, Kenneth J, Vaz M, Doherty TM, Jahnsen FL; TB Trials Study Group.
\nPLoS One. 2014 Jul 3;9(7):e101224. PMID: 24992314<\/p>\n

Haemodynamic differences between pancuronium and vecuronium in an experimental pig model.
\n<\/a>Grong K, Salminen PR, Stangeland L, Dahle GO.
\nVet Anaesth Analg. 2014 Jul 2. PMID: 24985148<\/p>\n

Maternal hormonal contraceptive use and offspring overweight or obesity.
\n<\/a>Jensen ET, Daniels JL, St\u00fcrmer T, Robinson WR, Williams CJ, Moster D, Juliusson PB, Vejrup K, Magnus P, Longnecker MP.
\nInt J Obes (Lond). 2014 Jul 2. PMID: 24984751<\/p>\n

Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy.
\n<\/a>Gjertsen BT, Sch\u00f6ffski P.
\nLeukemia. 2014 Jul 16. PMID: 25027517<\/p>\n

The C-terminal half of the \u03b12C-adrenoceptor determines the receptor’s membrane expression level and drug selectivity.
\n<\/a>Jahnsen JA, Uhl\u00e9n S.
\nNaunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1031-40. PMID: 23868076<\/p>\n

ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes.
\n<\/a>Ussar S, Lee KY, Dankel SN, Boucher J, Haering MF, Kleinridders A, Thomou T, Xue R, Macotela Y, Cypess AM, Tseng YH, Mellgren G, Kahn CR.
\nSci Transl Med. 2014 Jul 30;6(247):247ra103. PMID: 25080478<\/p>\n

Current status of molecular biomarkers in endometrial cancer.
\n<\/a>Werner HM, Salvesen HB.
\nCurr Oncol Rep. 2014 Sep;16(9):403. PMID: 25064587<\/p>\n

Myocardial injury in a 41-year-old male treated with methylphenidate: a case report.
\n<\/a>Hole LD, Schj\u00f8tt J.
\nBMC Res Notes. 2014 Jul 29;7:480. PMID: 25073534<\/p>\n

Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.
\n<\/a>Schj\u00f8tt J, Bergman J.
\nDrug Healthc Patient Saf. 2014 Jul 1;6:89-92. PMID: 25061339<\/p>\n

Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.
\n<\/a>Qui\u00f1ones M, Al-Massadi O, Fern\u00f8 J, Nogueiras R.
\nMol Cell<\/strong> Endocrinol. 2014 Aug 7. PMID: 25109279<\/p>\n

Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-\u03b3-mediated immune activation in the community-based Hordaland Health Study.
\n<\/a>Theofylaktopoulou D, Ulvik A, Midttun O, Ueland PM, Vollset SE, Nyg\u00e5rd O, Hustad S, Tell GS, Eussen SJ.
\nBr J Nutr. 2014 Aug 8:1-8. PMID: 25105221<\/p>\n

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.<\/a>
\nFrentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, J\u00f8rgensen LB, K\u00fccherer C, Struck D, Schmit JC, Vercauteren J, Asj\u00f6 B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-St\u00f6ckl E, S\u00f6nnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme.
\nBMC Infect Dis. 2014 Jul 21;14:407. PMID: 25047543<\/p>\n

Akutt promyelocyttleukemi.
\n<\/a>Reikvam H, Hovland R, Bruserud O.
\nTidsskrift for den Norske laegeforening 2014 May 27;134:1052-5. Norwegian.<\/p>\n

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.
\n<\/a>Koro C, Bielecka E, Dahl-Knudsen A, Enghild JJ, Scavenius C, Brun JG, Binder V, Hellvard A, Bergum B, Jonsson R, Potempa J, Blom AM, Mydel P.
\nEur J Immunol. 2014 Aug 13. PMID: 25130613<\/p>\n

Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix.
\n<\/a>Halle MK, Krakstad C, Engerud H, Bertelsen B, Salvesen HB.
\nPathol Res Pract. 2014 Jul 22. PMID: 25123963<\/p>\n

Irritable bowel syndrome and chronic fatigue six years after Giardia infection: a controlled prospective cohort study.
\n<\/a>Hanevik K, Wensaas KA, Rortveit G, Eide GE, M\u00f8rch K, Langeland N.
\nClin Infect Dis. 2014 Aug 12. PMID: 25115874<\/p>\n

One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
\n<\/a>Tandstad T, St\u00e5hl O, H\u00e5kansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, S\u00f6derstr\u00f6m K, Cavallin-St\u00e5hl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G; on behalf of SWENOTECA.
\nAnn Oncol. 2014 Aug 11. PMID: 25114021<\/p>\n

[Cardiac resynchronization therapy in heart failure–Norwegian guidelines].
\n<\/a>Holm T, F\u00e6restrand S, Larsen AI, J\u00f8nland KB, Gullestad L, Dickstein K, K\u00f6pp U, Sirnes PA, Tande P, Steen T, Kongsg\u00e5rd E.
\nTidsskr Nor Laegeforen. 2014 May 27;134(10):E1-17. Norwegian. PMID: 24865746<\/p>\n

[Cardiovascular risk assessment for the use of ADHD drugs in children].
\n<\/a>Berg A, Br\u00e5tane E, Odland HH, Brudvik C, Rosland B, Hirth A.
\nTidsskr Nor Laegeforen. 2014 Apr 8;134(7):710-4. Review. Norwegian. PMID: 24721858<\/p>\n

Effects of neonatal programming on hypothalamic mechanisms controlling energy balance.
\n<\/a>Contreras C, Novelle MG, Leis R, Di\u00e9guez C, Skrede S, L\u00f3pez M.
\nHorm Metab Res. 2013 Dec;45(13):935-44. PMID: 23913119<\/p>\n

Based on last week\u2019s search for<\/b><\/i><\/b> \u201c<\/i>Department of Clinical Science AND Bergen<\/i><\/strong>\u201d.<\/i> If you have publications which are not covered by this search, send the reference to <\/i><\/b>olivera.bozickovic@k2.uib.no<\/i><\/b><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Uker 27-34\/2014. Weeks 27-34\/2014.<\/p>\n

Read more →<\/a><\/p>\n","protected":false},"author":2812,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43440],"tags":[52320],"class_list":["post-3939","post","type-post","status-publish","format-standard","hentry","category-nye-publikasjoner-i-embase","tag-52320"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/3939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/2812"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=3939"}],"version-history":[{"count":3,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/3939\/revisions"}],"predecessor-version":[{"id":3973,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/3939\/revisions\/3973"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=3939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=3939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=3939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}